Ulcers

18 registered clinical trials studyying Ulcers — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	TrueLok Elevate PMCF Study NCT07079774	Orthofix s.r.l.	—
Enrolling By Invitation	Study on the Effectiveness of Hypothermal Sulphurous Water in Wound Hygiene NCT06725797	University of Roma La Sapienza	N/A
Terminated	Effect of NIRS-assisted Assessment on Chronic Lower Extremity and Other Chronic Non-healing Ulcers NCT06702852	Kent Imaging Inc	N/A
Completed	Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2) NCT04274049	Beijing Northland Biotech. Co., Ltd.	Phase 3
Completed	Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1) NCT04275323	Beijing Northland Biotech. Co., Ltd.	Phase 3
Completed	Peripheral Vascular Disease and Nerve Stimulation NCT01942941	Hull University Teaching Hospitals NHS Trust	N/A
Completed	Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia NCT01548378	Beijing Northland Biotech. Co., Ltd.	Phase 2
Completed	Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients NCT01474109	Actelion	Phase 3
Terminated	Insulin Infusion Diabetes Ulcer NCT00700154	Karolinska Institutet	N/A
Completed	Utility of Interface Pressure Mapping NCT01439581	Henry Ford Health System	N/A
Completed	A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers NCT01138436	Skingenix, Inc.	Phase 2
Completed	Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulce NCT01214811	Molnlycke Health Care AB	Phase 3
Completed	SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds NCT00951080	3M	N/A
Completed	Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination NCT00688428	AstraZeneca	Phase 1
Suspended	Non-inferiority Clinic of Kollagenase® Compared Iruxol® in Treatment of Cutaneous Ulcers NCT00701974	Azidus Brasil	Phase 2 / Phase 3
Completed	Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury NCT00597818	Sucampo Pharma Americas, LLC	Phase 2
Completed	Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Pati NCT00189540	AnGes USA, Inc.	Phase 2
Completed	Clinical Application of Autologous Three-Cellular Cultured Skin Substitutes (CSS) NCT00718978	University of Roma La Sapienza	N/A